Antibiotic | Resistance profile | P-value* | ||
---|---|---|---|---|
Sensitive | Intermediate | Resistant | ||
Ticracillin /Tazobactam | Â | Â | Â | Â |
Male Female | 5 0 | 13 7 | 23 5 | 0.168 |
Tigycyclin | Â | Â | Â | Â |
Male Female | 9 2 | 21 5 | 11 5 | 0.314 |
Chloramphenicol | Â | Â | Â | Â |
Male Female | 17 4 | 7 1 | 17 7 | 0.547 |
Cefuroxime | Â | Â | Â | Â |
Male Female | 2 4 | 6 1 | 33 7 | 0.063 |
Cefazolin | Â | Â | Â | Â |
Male Female | 0 0 | 0 0 | 41 12 | N/A |
Imipineme | Â | Â | Â | Â |
Male Female | 12 7 | 10 0 | 19 5 | 0.076 |
Gentamycin | Â | Â | Â | Â |
Male Female | 21 5 | 4 1 | 16 6 | 0.794 |
Ampicillin/Sulbactam | Â | Â | Â | Â |
Male Female | 3 1 | 3 2 | 35 9 | 0.609 |
Amoxicillin/Clavulanic | Â | Â | Â | Â |
Male Female | 3 3 | 9 0 | 29 9 | 0.073 |
Ceftazidime | Â | Â | Â | Â |
Male Female | 1 0 | 5 2 | 35 10 | 0.803 |
Levofloxacin | Â | Â | Â | Â |
Male Female | 27 8 | 3 0 | 11 4 | 0.601 |
Ciprofloxacin | Â | Â | Â | Â |
Male Female | 24 6 | 4 2 | 13 4 | 0.772 |
Trimethoprim/Sulfamethoxazole | Â | Â | Â | Â |
Male Female | 11 5 | 6 3 | 24 4 | 0.304 |